Study record · Thymalin
Thymalin added to standard treatment in non-specific pulmonary disease
Thymalin was associated with normalization of lymphocyte count and OKT-4+/OKT-8+ subpopulations; little effect was reported on several other immune measures.
Key result
Thymalin was associated with normalization of lymphocyte count and OKT-4+/OKT-8+ subpopulations; little effect was reported on several other immune measures.
Study details
Study designSmall controlled clinical study
PopulationPatients with non-specific pulmonary diseases
Sample size35
RouteInjection
Regimen / exposure21 received Thymalin plus standard treatment; 14 control; 4-6 injections reported
DurationTreatment course
ComparatorStandard treatment control
Primary endpoint / questionCellular immune markers and clinical course
Safety resultModern adverse-event reporting was not provided.
Key limitationsVery small, old Russian study; surrogate immune endpoints and limited generalizability.
Registry / identifierPMID 2741122